Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
There’s an article in today’s Wall Street Journal that begins, “Scientists may soon be able to answer the agonizing question facing men with prostate cancer.” The agonizing question is whether a specific individual actually needs early and aggressive treatment for his cancer or can simply monitor it for risk of progression.
Filed under: Diagnosis, Management, Risk | Tagged: classification, genetics, profiling, progression, risk | 3 Comments »
FRET stands for “fluorescence resonance-energy transfer.” It’s a way to assess interactions between individual protein molecules, and allows researchers to find out how many receptors of specific types there are in a specific cancer specimen as well as how active those receptors are.
Filed under: Diagnosis, Risk, Uncategorized | Tagged: classification, FRET, pathology | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site